Global Medical REIT Inc GMRE.N, GMRE.K is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2025
The Bethesda Maryland-based company is expected to report a 1.0% increase in revenue to $35.478 million from $35.12 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for Global Medical REIT Inc is for earnings of 1 cent per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Global Medical REIT Inc is $10.00, above its last closing price of $7.81.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
0.19
0.20
0.15
Missed
-24.5
Sep. 30 2024
0.21
0.20
0.19
Missed
-6.6
Jun. 30 2024
0.20
0.20
0.20
Met
-0.6
Mar. 31 2024
0.21
0.21
0.21
Met
0.6
Dec. 31 2023
0.22
0.22
0.19
Missed
-13.2
Sep. 30 2023
0.21
0.21
0.22
Beat
4.2
Jun. 30 2023
0.22
0.22
0.21
Missed
-5.5
Mar. 31 2023
0.23
0.23
0.22
Missed
-5.3
This summary was machine generated May 5 at 20:12 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)